s6y
Company name or ticker
Search
Larimar Therapeutics, Inc.
424B5
Prospectus filed pursuant to Rule 424(b)(5)
Filed
Thursday, June 28, 2018
Accession number
0001193125-18-207757
Documents
Prospectus filed pursuant to Rule 424(b)(5)
424B5
On sec.gov
Filing index
All files
Complete submission text
SGML header